- Home
- CELC vs CPZ Comparison
CELC vs CPZ Comparison
Compare CELC & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CPZ
- Stock Information
- Founded
- CELC 2011
- CPZ 2019
- Country
- CELC United States
- CPZ United States
- Employees
- CELC N/A
- CPZ N/A
- Industry
- CELC Medical Specialities
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- CELC Health Care
- CPZ Finance
- Exchange
- CELC Nasdaq
- CPZ Nasdaq
- Market Cap
- CELC 327.3M
- CPZ 300.6M
- IPO Year
- CELC 2017
- CPZ N/A
- Fundamental
- Price
- CELC $10.24
- CPZ $15.13
- Analyst Decision
- CELC Strong Buy
- CPZ
- Analyst Count
- CELC 6
- CPZ 0
- Target Price
- CELC $30.17
- CPZ N/A
- AVG Volume (30 Days)
- CELC 392.7K
- CPZ 63.0K
- Earning Date
- CELC 05-14-2025
- CPZ 01-01-0001
- Dividend Yield
- CELC N/A
- CPZ 11.07%
- EPS Growth
- CELC N/A
- CPZ N/A
- EPS
- CELC N/A
- CPZ N/A
- Revenue
- CELC N/A
- CPZ N/A
- Revenue This Year
- CELC N/A
- CPZ N/A
- Revenue Next Year
- CELC N/A
- CPZ N/A
- P/E Ratio
- CELC N/A
- CPZ N/A
- Revenue Growth
- CELC N/A
- CPZ N/A
- 52 Week Low
- CELC $7.58
- CPZ $13.17
- 52 Week High
- CELC $19.77
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- CELC 54.38
- CPZ 46.54
- Support Level
- CELC $7.58
- CPZ $14.83
- Resistance Level
- CELC $10.48
- CPZ $15.20
- Average True Range (ATR)
- CELC 1.04
- CPZ 0.40
- MACD
- CELC 0.17
- CPZ -0.01
- Stochastic Oscillator
- CELC 80.01
- CPZ 57.35
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.